THY1 / CD90 Antibody (Antigen Affinity Purified)

Mouse Thy-1 Membrane Glycoprotein Antibody ( Antigen Affinity Purified )

THY1 / CD90 Antibody Product Information

• Immunogen: Recombinant mouse THY1 protein ( Catalog #50461-M08H )
• Antibody Type: Rabbit Polyclonal Antibody ( Antibody Purification Platform )
• Ig Type: Rabbit IgG
• Formulation: 0.2 μm filtered solution in PBS with 5% trehalose
• Preparation: Produced in rabbits immunized with purified, human cell-derived, recombinant mouse THY1 ( rM THY1 ; Catalog #50461-M08H ; NP_033408.1 ; Met 1 - Cys 131 ). THY1 specific IgG was purified by mouse THY1 affinity chromatography

THY1 / CD90 Antibody Usage Guide

• Specificity: Mouse THY1 / CD90
• Western blot: This antibody can be used at 0.1 - 0.2 μg/mL with the appropriate secondary reagents to detect mouse THY1 in WB. Using a DAB detection system, the detection limit for mouse THY1 is approximately 2 ng/lane under non-reducing conditions and reducing conditions
• Direct ELISA: This antibody can be used at 0.1 - 0.2 μg/mL with the appropriate secondary reagents to detect mouse THY1. The detection limit for mouse THY1 is approximately 0.039 ng/well
• Storage: This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
  Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

THY1 / CD90 Antibody Background

Mouse Thy-1 membrane glycoprotein, also known as Thy-1 antigen, CD90 and THY1, is a cell membrane protein which contains 1 Ig-like V-type (immunoglobulin-like) domain. THY1 / CD90, a member of the immunoglobulin superfamily of adhesion molecules with constitutive expression on fibroblast cells. THY1 / CD90 is a cell surface glycoprotein originally identified on mouse thymocytes. It has been identified on a variety of stem cells and at varying levels in non-lymphoid tissues such as on fibroblasts, brain cells, and activated endothelial cells. THY1 / CD90 is a membrane glycoprotein expressed in thymus, retinal ganglionic cells, and several types of stem cells. It was observed that THY1 / CD90 cell surface expression decreased significantly during the course of infection. In adult rats, expression of THY1 / CD90 on the B cell lineage is confined to immature B cells. The expression of THY1 / CD90 on neonatal MZ-B cells may have implications for their responsiveness to polysaccharide (T cell-independent type 2) antigens. THY1 / CD90 is modulated following infection with Human cytomegalovirus (HCMV). Neuroblastoma (NBL) is the most common solid tumor in children. THY1 / CD90 seemed to be a marker with a specific prognostic value in NBL patients. THY1 / CD90 may also play a role in cell-cell or cell-ligand interactions during synaptogenesis and other events in the brain.

References

1. Dammers, PM. et al., 2002, Dev Immunol  9 (4):187-95.
2. Leis,M. et al., 2004, J Gen Virol 85 (Pt 7):1995-2000.
3. Wiesmann,A. et al., 2006, Head Face Med 2 :8.
4. Fiegel, HC. et al., 2008, Pediatr Surg Int  24 (1):101-5.
5. Kisselbach,L. et al., 2009, Cytotechnology. 59 (1): 31-44.